[68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia

医学 核医学 慢性淋巴细胞白血病 病理 骨髓 标准摄取值 淋巴瘤 白血病 正电子发射断层摄影术 内科学
作者
Marius E. Mayerhoefer,Ulrich Jaeger,Philipp B. Staber,Markus Raderer,Wolfgang Wadsak,Sarah Pfaff,Christoph Kornauth,Dietrich Beitzke,Michael Weber,Hans‐Juergen Wester,Cathrin Skrabs,Alexander Haug
出处
期刊:Investigative Radiology [Ovid Technologies (Wolters Kluwer)]
卷期号:53 (7): 403-408 被引量:49
标识
DOI:10.1097/rli.0000000000000469
摘要

Objectives This prospective proof-of-principle study aimed to determine whether [ 68 Ga]Ga-Pentixafor uptake, which reflects CXCR4 expression, is higher in the bone marrow of chronic lymphocytic leukemia (CLL) than in other oncological diseases without bone marrow infiltration and can therefore be used for CLL imaging. Materials and Methods Thirteen CLL patients and 20 controls (10 with pancreatic adenocarcinoma and 10 with mucosa-associated lymphoid tissue lymphoma) with histologically proven cancer underwent [ 68 Ga]Ga-Pentixafor positron emission tomography/magnetic resonance imaging. Standardized [ 68 Ga]Ga-Pentixafor uptake values (SUV max , SUV mean ) were measured in the bone marrow of the pelvis, the lumbar vertebra L4, and the bony structure with the visually highest tracer uptake (“hottest lesion”). Mean apparent diffusion coefficient values were also measured in the pelvis. Serum leukocyte count (gram per liter), lymphocyte percentage (percent), lactate dehydrogenase (unit per liter), β2-microglobulin (milligram per deciliter), and C-reactive protein (milligram per deciliter) were measured. Statistical analyses comprised analysis of variance with Games-Howell post hoc tests and Spearman correlation coefficients. Results SUV max and SUV mean differed significantly between CLL and pancreatic adenocarcinoma in the pelvis ( P = 0.032 and P = 0.008) and lumbar vertebra L4 (both P < 0.001). SUV mean also differed in the pelvis ( P = 0.020) and L4 ( P = 0.041), and SUV max in L4 ( P = 0.019), between CLL and mucosa-associated lymphoid tissue lymphoma. Receiver operating characteristic–based areas under the curve for separation of CLL from the control groups were greatest for the SUV max of the bony structure with the strongest [ 68 Ga]Ga-Pentixafor uptake (0.94) and the SUV max of L4 (0.92). There was no significant correlation between [ 68 Ga]Ga-Pentixafor uptake and pelvic apparent diffusion coefficients or serum parameters. Conclusions [ 68 Ga]Ga-Pentixafor positron emission tomography/magnetic resonance imaging may possibly be useful for CXCR4-based CLL imaging.

科研通智能强力驱动
Strongly Powered by AbleSci AI

祝大家在新的一年里科研腾飞
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yzizz完成签到 ,获得积分10
1秒前
2秒前
2秒前
2秒前
2秒前
科研通AI6.1应助科研通管家采纳,获得150
2秒前
2秒前
顾矜应助科研通管家采纳,获得10
2秒前
在水一方应助科研通管家采纳,获得10
2秒前
ding应助科研通管家采纳,获得10
2秒前
Hello应助科研通管家采纳,获得10
2秒前
小蘑菇应助科研通管家采纳,获得10
2秒前
2秒前
ding应助科研通管家采纳,获得10
2秒前
Lucas应助科研通管家采纳,获得10
2秒前
共享精神应助科研通管家采纳,获得10
2秒前
传奇3应助科研通管家采纳,获得10
3秒前
慕青应助科研通管家采纳,获得10
3秒前
CipherSage应助科研通管家采纳,获得10
3秒前
ding应助科研通管家采纳,获得10
3秒前
小蘑菇应助科研通管家采纳,获得10
3秒前
酷波er应助科研通管家采纳,获得10
3秒前
阿楷完成签到,获得积分10
3秒前
李暴龙完成签到,获得积分10
7秒前
8秒前
WeiJX完成签到,获得积分10
8秒前
牛的不low的完成签到,获得积分10
9秒前
木日完成签到,获得积分10
10秒前
11秒前
马子妍发布了新的文献求助10
13秒前
13秒前
15秒前
NexusExplorer应助Rainsoul采纳,获得30
15秒前
2327发布了新的文献求助10
18秒前
19秒前
华仔应助lxj采纳,获得10
20秒前
稳重的蛟凤应助黑桃采纳,获得20
20秒前
害羞大碗完成签到,获得积分20
21秒前
renjing574完成签到,获得积分10
22秒前
上官若男应助jewelliang采纳,获得10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de guyane 2500
Signals, Systems, and Signal Processing 510
Discrete-Time Signals and Systems 510
The Dance of Butch/Femme: The Complementarity and Autonomy of Lesbian Gender Identity 500
Driving under the influence: Epidemiology, etiology, prevention, policy, and treatment 500
Differentiation Between Social Groups: Studies in the Social Psychology of Intergroup Relations 350
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5877672
求助须知:如何正确求助?哪些是违规求助? 6544764
关于积分的说明 15681969
捐赠科研通 4996370
什么是DOI,文献DOI怎么找? 2692684
邀请新用户注册赠送积分活动 1634715
关于科研通互助平台的介绍 1592364